Castle Biosciences Inc
CSTL
Market Cap$535.55M
Close$
$33.86
53.7% upside
Current Fair Value
53.7% upsideUndervalued by 53.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $535.55 Million |
|---|---|
| Enterprise Value | $307.76 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.14 |
| Beta | 0.0 |
| Outstanding Shares | 27,449,983 |
| Avg 30 Day Volume | 153,311 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.32 |
|---|---|
| PEG | 10.65 |
| Price to Sales | 2.75 |
| Price to Book Ratio | 1.57 |
| Enterprise Value to Revenue | 1.4 |
| Enterprise Value to EBIT | -4.53 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
ESG Score
No data